Compare Sanofi SA (SNY) vs Tidewater Inc (TDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs Tidewater Inc — how do they compare? Sanofi SA trades at $40.04 (market cap $95.18B), while Tidewater Inc trades at $84.9 (market cap $4.21B). The key difference: Sanofi SA is far larger — about 22.6× Tidewater Inc's market cap, and Sanofi SA pays a 6.01% dividend while Tidewater Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and Tidewater Inc for 26 Days on average.
| SNY | TDW | |
|---|---|---|
Market Cap | $95.18B | $4.21B |
Volume | 2,995,646 | 590,005 |
Sector | Health | Energy |
52-Week High | $52.34 | $100.61 |
52-Week Low | $39.51 | $47.29 |
Typical Hold Time | 94 Days | 26 Days |
Enterprise Value | $114.48B | $4.25B |
Dividend Yield | 6.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sanofi (SNY) trades at $40.07, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.21 exceeding the $1.10 estimate. Revenue for 2025 reached $46.72 billion, with a net income margin of 16.72%. Recent news highlights a significant $8 billion immunology alliance expansion with Regeneron, signaling strategic growth initiatives.
The outlook is mixed; solid profitability and a strategic partnership provide upside potential, but a projected net income decline to $4.0 billion in 2026 and bearish technical indicators pose risks. Analyst sentiment is cautiously optimistic with a 44% buy rating, though investors should monitor execution of new collaborations and patent expiration impacts.
Tidewater (TDW) trades at $85.42, up 2.42% with bullish technical indicators and strong institutional interest. The company maintains solid profitability with 18.34% net margin and 19.49% ROE, though recent quarterly earnings have missed expectations. Recent acquisition of Wilson Sons Ultratug expands offshore services capabilities, while BlackRock's $503 million investment signals confidence in long-term prospects.
TDW presents a mixed outlook with analyst consensus target of $105.50 offering 23% upside potential, but faces execution risks from recent earnings misses and Middle East operational costs. The stock's valuation at 17.18 P/E appears reasonable given growth prospects, though investors should monitor quarterly performance consistency and integration of recent acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About Tidewater Inc
Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →
